Skip to main content

OmniStar Financial Group, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1698777 Wilmington, NC

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$3,239,862
-$149,477 QoQ
Shares Held
25,644
+5.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.05%
of 13F equity value
Holder Rank
#694
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2021
CallValue
$805,455
CallShares
11,697
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

OmniStar Financial Group, Inc. holds $15,740,872 across 7 Drug Manufacturers - General names. GILD ranks #2 (20.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
25,644 $3,239,862

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,239,862 25,644
2026-03-31 $3,389,339 24,319
2025-12-31 $4,154,994 33,852
2025-09-30 $3,449,103 31,073
2025-06-30 $1,658,171 14,956
2025-03-31 $1,373,620 12,259
2024-12-31 $1,642,708 17,784
2024-09-30 $830,602 9,907
2024-06-30 $689,942 10,056
2024-03-31 $672,654 9,183
2023-12-31 $826,788 10,206
2023-09-30 $1,276,378 17,032
2023-06-30 $1,313,272 17,040
2023-03-31 $1,421,525 17,133
2022-12-31 $1,314,964 15,317
2022-09-30 $1,454,403 23,576
2022-06-30 $1,259,935 20,384
2022-03-31 $1,195,539 20,110
2021-12-31 $973,845 13,412
2021-09-30 $820,667 11,749
2021-06-30 $805,455 11,697
2021-03-31 $746,735 11,554
2020-12-31 $1,006,732 17,280
2020-09-30 $1,167,624 18,478
2020-06-30 $740,855 9,629
2020-03-31 $597,108 7,987